We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Nausea, vomiting and quality of life of patients with cancer undergoing antineoplastic treatment: an evaluation by pharmacists.
- Authors
Souza, Cinthia Madeira; Visacri, Marília Berlofa; Ferrari, Graziele Baldan; Tuan, Bruna Taliani; Costa, Anna Paula Lourenço; Barbosa, Cristina Rosa; Lima, Carmen Silvia P.; Mazzola, Priscila Gava; Moriel, Patrícia
- Abstract
Objective This study aims to evaluate the frequency and severity of nausea and vomiting using two different instruments and relate them to quality of life ( QOL) in patients with cancer receiving antineoplastic treatment. Methods Severity of chemotherapy-induced nausea and vomiting ( CINV) was measured by Common Terminology Criteria for Adverse Events ( CTCAE) and a numerical scale. QOL was assessed using the Functional Assessment of Cancer Therapy-General questionnaire. Key findings Of the 50 patients studied, 60.0% reported nausea (40.0% CTCAE grade 1; 66.7% moderate intensity on numerical scale) and 30.0% reported vomiting (46.7% CTCAE grades 1 and 2, each; 66.7% moderate intensity on numerical scale). CINV did not influence overall QOL. Conclusion The frequency of CINV was high. There was no association between nausea/vomiting and overall QOL.
- Subjects
STOMATITIS; ANTINEOPLASTIC agents; CANCER chemotherapy; CANCER patients; INFUSION therapy equipment; INTRAVENOUS therapy; MEDICAL cooperation; PHARMACISTS; PHARMACOLOGY; QUALITY of life; RESEARCH; RESEARCH funding; TERMS &; phrases; CROSS-sectional method; DIAGNOSIS
- Publication
International Journal of Pharmacy Practice, 2015, Vol 23, Issue 5, p357
- ISSN
0961-7671
- Publication type
Article
- DOI
10.1111/ijpp.12169